CIK 0001023024
- Large accelerated filer
ANI PHARMACEUTICALS INC
Sign in to watch- Ticker
- ANIP
- Exchange
- Nasdaq
- Industry
- Pharmaceutical Preparations
- FY end
- Dec 31
- Incorporated
- DE
- Entity type
- Operating
- EIN
- 582301143
- Phone
- +1 609-759-1810
- Business address
- 104 CARNEGIE CENTER DRIVE SUITE 300, PRINCETON, NJ, 08540
- Former names
- BIOSANTE PHARMACEUTICALS INC, BEN ABRAHAM TECHNOLOGIES INC
- Open-market buys, last 90 days
- $0
- in 0 filings
- Open-market sales, last 90 days
- $2,359,736
- in 11 filings, $2.4M under 10b5-1 plans
Net −$2,359,736. Shares bought or sold at a price by officers, directors and 10% owners (Form 4 codes P and S). Grants, option exercises and tax withholding aren't counted.
Who's trading
90 days
Reading 100 more Form 4s from the SEC; this list fills in as they're read.
| Date | Insider | Transaction | Shares | Price | Value | Owned after |
|---|---|---|---|---|---|---|
| 2018-03-15 | RAYNOR DANIEL Director | Sale | −1,902 | $61.50 | $117K | 294,316 |
| 2018-03-14 | MARSHBANKS TRACY Director | Sale | −1,912 | $63.10 | $121K | 483,801 |
| 2018-03-14 | PRZYBYL ARTHUR President and CEO | Sale | −10,000 | $62.03 | $620K | 185,706 |
| 2018-03-14 | RAYNOR DANIEL Director | Sale | −1,919 | $62.02 | $119K | 296,218 |
| 2018-03-13 | PRZYBYL ARTHUR President and CEO | Sale | −23,475 | $61.52 | $1.4M | 202,231 |
| 2018-03-13 | PRZYBYL ARTHUR President and CEO | Sale | −6,525 | $62.63 | $409K | 195,706 |
| 2018-03-13 | RAYNOR DANIEL Director | Sale | −14,000 | $61.81 | $865K | 302,254 |
| 2018-03-13 | RAYNOR DANIEL Director | Sale | −4,117 | $62.59 | $258K | 298,137 |
| 2018-03-12 | PRZYBYL ARTHUR President and CEO | Exercise or conversion | +15,723 | $6.36 | $100K | 225,706 |
| 2018-03-12 | PRZYBYL ARTHUR President and CEO | Exercise or conversion · Stock Option | −15,723 | 0 | ||
| 2018-03-12 | RAYNOR DANIEL Director | Sale | −7,928 | $62.88 | $499K | 316,254 |
| 2018-03-12 | MARSHBANKS TRACY Director | Sale | −12,269 | $63.03 | $773K | 485,713 |
| 2018-03-09 | MARSHBANKS TRACY Director | Sale | −36,561 | $63.01 | $2.3M | 497,982 |
| 2018-03-08 | MARSHBANKS TRACY Director | Sale | −15,391 | $63.08 | $971K | 534,543 |
| 2018-03-05 | Marken James G. SVP Ops & Prod Dev | Exercise or conversion | +14,793 | $6.36 | $94K | 66,439 |
| 2018-03-05 | Marken James G. SVP Ops & Prod Dev | Exercise or conversion | +3,208 | $33.00 | $106K | 69,647 |
| 2018-03-05 | Marken James G. SVP Ops & Prod Dev | Sale | −4,177 | $61.92 | $259K | 65,470 |
| 2018-03-05 | Marken James G. SVP Ops & Prod Dev | Exercise or conversion · Stock Options | −14,793 | 0 | ||
| 2018-03-05 | Marken James G. SVP Ops & Prod Dev | Exercise or conversion · Stock Options | −3,208 | 1,667 | ||
| 2018-03-01 | Schrepfer Robert W SVP - New Bus Dev & Spec Sales | Exercise or conversion | +18,750 | $28.76 | $539K | 41,590 |
Page 33 of 41 · 804 trades